Page last updated: 2024-10-26

valproic acid and Somatostatinoma

valproic acid has been researched along with Somatostatinoma in 1 studies

Valproic Acid: A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS.
valproic acid : A branched-chain saturated fatty acid that comprises of a propyl substituent on a pentanoic acid stem.

Somatostatinoma: A SOMATOSTATIN-secreting tumor derived from the pancreatic delta cells (SOMATOSTATIN-SECRETING CELLS). It is also found in the INTESTINE. Somatostatinomas are associated with DIABETES MELLITUS; CHOLELITHIASIS; STEATORRHEA; and HYPOCHLORHYDRIA. The majority of somatostatinomas have the potential for METASTASIS.

Research Excerpts

ExcerptRelevanceReference
"To determine the role of gamma-aminobutyric acid (GABA) in islet tissue, sodium valproate (1600 mg/day) was administered for 6 days to 10 normal subjects and 1 patient with a somatostatinoma."5.06The effects of sodium valproate on plasma somatostatin and insulin in humans. ( Fujita, S; Ichii, S; Kusunoki, M; Nakai, T; Utsunomiya, J; Yamamura, T, 1988)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kusunoki, M1
Yamamura, T1
Ichii, S1
Fujita, S1
Nakai, T1
Utsunomiya, J1

Trials

1 trial available for valproic acid and Somatostatinoma

ArticleYear
The effects of sodium valproate on plasma somatostatin and insulin in humans.
    The Journal of clinical endocrinology and metabolism, 1988, Volume: 67, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Blood Glucose; C-Peptide; Female; gamma-Aminobutyric Acid; Humans; I

1988